Alembic Pharmaceuticals Ltd
Manuj Desai has extensive experience in technology and information management, currently serving as the Chief Technology & Information Officer at Alembic Pharmaceuticals Limited since January 2024. Prior to this role, Desai was the Global Chief Information Officer and Global Head of Technology Transformation at STL - Sterlite Technologies Limited from 2019 to December 2023. Desai held significant positions at AIG from 2014 to 2018, including Senior Director and India Head for Personal Insurance, and Director of Integration Services and Innovation. Earlier career highlights include roles at PayPal, the United States Department of Agriculture, Amedisys, Sprint, Unique Computing, and Applitech Solution Ltd. Desai holds a Master's degree in Project Management from The George Washington University and a Bachelor's degree in Engineering from Bharati Vidyapeeth.
This person is not in any teams
This person is not in any offices
Alembic Pharmaceuticals Ltd
8 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.